Company intelligence / Profile preview

Sai Life Sciences

Hyderabad, Telangana, Indiapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~2845
Development stage: Other

Overview

Sai Life Sciences is an end-to-end CRDMO supporting global pharma and biotech companies with drug discovery through commercial manufacturing. It has enabled 170+ pharmaceutical products in its pipeline and supported the manufacture of 28 commercial drugs as of September 2024. Seven of these are blockbuster drugs (>USD 1B annual sales)[6][8].

Modalities: Small moleculePeptides
Industry: Drug Discovery Services

Partnerships

Works with over 280 global pharma/biotech companies including many top-tier firmsincludes “18 of the top 25” global pharma companies as customers

Beyond the preview

Go deeper on Sai Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sai Life Sciences.

Explore the full profile